Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tyco Medical Products Sales To Hit $4.5 Bil. With U.S. Surgical Acquisition

This article was originally published in The Gray Sheet

Executive Summary

Tyco International's medical device business will reach $4.5 bil. following the $3.3 bil. purchase of U.S. Surgical Corp. The total includes USSC's estimated $1.4 bil. in 1998 sales and revenue from Tyco's previous acquisitions of Sherwood-Davis & Geck and Kendall, making up a substantial portion of the conglomerate's overall $13 bil. in annual volume.

You may also be interested in...

Tyco Urology Franchise Leaps Ahead With $3.2 Bil. Bard Acquisition

Tyco International will increase its total health care sales to about $7.6 bil. annually through acquisition of C.R. Bard for approximately $3.2 bil. in stock. Valued at nearly three times Bard's 2000 sales of $1.1 bil., the definitive agreement was announced May 30.

Market Intel: Minimally Invasive Procedures Gaining Traction In BPH Treatment Market

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts